Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #104

Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed androgen deprivation therapy in combination with external beam radiotherapy to the prostate.

Submission Methods: Registry
Measure Sets: Urology

There are no codes for this QPP measure yet (code lists for the current year may not have been established yet).

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.